vaccine, japanese encephalitis


sanofi pasteur


Concise Prescribing Info
Live, attenuated, recombinant Japanese encephalitis virus (propagated in Vero cells)
Prophylaxis of Japanese encephalitis caused by Japanese encephalitis virus in individuals from ≥9 mth.
Dosage/Direction for Use
Primary vaccination Childn ≥9 mth 0.5 mL single inj. Booster Adult ≥18 yr No need for booster dose up to 5 yr after primary vaccination. Childn 9 mth-17 yr 12-24 mth after primary vaccination.
History of severe allergic reaction. Postpone vaccination in case of febrile or acute disease. Congenital or acquired immune deficiency impairing cellular immunity including immunosuppressive therapies eg, chemotherapy & high doses of systemic corticosteroids given for ≥14 days; symptomatic or asymptomatic HIV infection. Pregnancy & lactation.
Special Precautions
History of serious or severe reaction w/in 48 hr of a previous inj w/ a vaccine. Do not administer intravascularly. Patients following treatment w/ high-doses of systemic corticosteroids given for ≥14 days should be administered at least ≥1 mth before vaccination. Not recommended in childn <9 mth.
Adverse Reactions
Fatigue, malaise, inj site pain; headache; myalgia. Feeling hot, chills, inj site erythema, pruritus, swelling & bruising; dizziness; arthralgia; diarrhoea, nausea, abdominal pain, vomiting; pharyngolaryngeal pain, dyspnoea, rhinorrhea, cough, wheezing, nasal congestion; rash. Childn: Malaise, irritability, appetite loss & crying.
Drug Interactions
Vaccination must not be performed w/in 6 wk & preferably not w/in 3 mth of inj of Ig or blood products containing Ig eg, blood or plasma to avoid neutralisation of the attenuated viruses.
ATC Classification
J07BA03 - encephalitis, Japanese, live attenuated ; Belongs to the class of encephalitis viral vaccines.
Imojev susp for inj 0.5 mL
(+ diluent) 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in